NCT03359317

Brief Summary

To test the changes in osteoarthritis according to the X-rays, and changes in bone quality before and 1 or more years after beginning the jogging

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 2, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

February 20, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2019

Completed
Last Updated

December 2, 2017

Status Verified

November 1, 2017

Enrollment Period

11 months

First QC Date

November 26, 2017

Last Update Submit

November 29, 2017

Conditions

Osteoporosis

Keywords

OsteoporosisBone Diseases

Outcome Measures

Primary Outcomes (1)

  • DEXA T-score

    Bone mineral density change in spine, hip and femur after 1 year of jogging

    1 year

Secondary Outcomes (1)

  • Number of fractures

    1 year

Study Arms (1)

jogging

EXPERIMENTAL

At least 5 times/week

Behavioral: jogging

Interventions

joggingBEHAVIORAL

Jogging as instructed for 1 year

jogging

Eligibility Criteria

Age50 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Past DEXA scan and, all within 6 months of study entry, DEXA scan and normal values for: Metabolic panel, TSH, PTH, ESR (or CRP), Vitamin D 25 hydroxy, Vitamin D 1,25 dihydroxy, Urine NTX

You may not qualify if:

  • Known metabolic bone disease such as osteogenesis imperfecta, current treatment with steroids, chemotherapy, or currently healing fractures of lumbar spine, hips or femurs, severe heart disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

OsteoporosisBone Diseases

Interventions

Jogging

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

RunningLocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Peixun Zhang, MD

    Peking University People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peixun Zhang, MD

CONTACT

15210802766875274428@qq.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of orthopaedics and trauma

Study Record Dates

First Submitted

November 26, 2017

First Posted

December 2, 2017

Study Start

February 20, 2018

Primary Completion

January 30, 2019

Study Completion

January 30, 2019

Last Updated

December 2, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share